AI Summary
- Pharmacovigilance data indicate an association between clozapine or olanzapine exposure and pulmonary embolism, warranting clinical awareness.
- Signal interpretation limited by underreporting, confounding medical risk factors, and inability to establish causality from spontaneous reports.
- Clinicians should assess venous thromboembolism risk, counsel patients, monitor for symptoms, and support prospective studies to clarify causality.
J Clin Psychopharmacol. 2026 Oct 19. doi: 10.1097/JCP.0000000000002285. Online ahead of print.
NO ABSTRACT
PMID:42895188 | DOI:10.1097/JCP.0000000000002285
Share Evidence Blueprint
Save to Google Notes
Search Google Scholar
Save as PDF
⭐ My Revision List
